0001104659-21-072624.txt : 20210526
0001104659-21-072624.hdr.sgml : 20210526
20210526213820
ACCESSION NUMBER: 0001104659-21-072624
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210517
FILED AS OF DATE: 20210526
DATE AS OF CHANGE: 20210526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murphy-Chutorian Douglas
CENTRAL INDEX KEY: 0001594342
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36305
FILM NUMBER: 21968306
MAIL ADDRESS:
STREET 1: C/O SEMLER SCIENTIFIC, INC.
STREET 2: 911 BERN COURT, SUITE 110
CITY: SAN JOSE
STATE: CA
ZIP: 95112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Semler Scientific, Inc.
CENTRAL INDEX KEY: 0001554859
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 261367393
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2340-2348 WALSH AVENUE, SUITE 2344
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
BUSINESS PHONE: 408-627-4557
MAIL ADDRESS:
STREET 1: 2340-2348 WALSH AVENUE, SUITE 2344
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
4
1
tm2117668-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-05-17
0
0001554859
Semler Scientific, Inc.
SMLR
0001594342
Murphy-Chutorian Douglas
C/O SEMLER SCIENTIFIC, INC.
2340-2348 WALSH AVENUE, SUITE 2344
SANTA CLARA
CA
95051
1
1
1
0
Chief Executive Officer
Common Stock
2021-05-17
4
S
0
458
103.0743
D
53113
I
By Trust
Common Stock
2021-05-17
4
S
0
335
104.0702
D
52778
I
By Trust
Common Stock
2021-05-17
4
S
0
292
105.312
D
52486
I
By Trust
Common Stock
2021-05-17
4
S
0
135
106
D
52351
I
By Trust
Common Stock
2021-05-17
4
S
0
30
107
D
52321
I
By Trust
Common Stock
2021-05-24
4
S
0
300
108.5833
D
52021
I
By Trust
Common Stock
2021-05-24
4
S
0
546
109.1398
D
51475
I
By Trust
Common Stock
2021-05-24
4
S
0
252
110.1083
D
51223
I
By Trust
Common Stock
2021-05-24
4
S
0
90
111.0889
D
51133
I
By Trust
Common Stock
2021-05-24
4
S
0
31
112.7290
D
51102
I
By Trust
Common Stock
2021-05-24
4
S
0
2
114.10
D
51100
I
By Trust
Common Stock
2021-05-24
4
S
0
29
115.99
D
51071
I
By Trust
Shares sold pursuant to a 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.75 to $103.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
Shares are held by the Murphy-Chutorian Family Trust U/D/T dated January 13, 1997, of which the Reporting Person is co-Trustee with his spouse.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.00 to $104.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.00 to $108.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 6 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.00 to $109.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 7 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 8 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.00 to $111.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 9 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.60 to $113.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 10 to this Form 4.
/s/ Dan Conger, attorney-in-fact
2021-05-26